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Abstract
Background:  Cardiovascular Magnetic Resonance (CMR) imaging offers methods for the
detection of ischemia and myocardial infarction as well as visualization of the coronary arteries
(MRCA). However, a direct comparison of adenosine perfusion (PERF), late gadolinium
enhancement (LGE) and MRCA or the results of their combination has not been performed. Aim
of the study was to evaluate the feasibility/diagnostic performance of rest/stress perfusion, late
gadolinium enhancement and MRCA and their combination in patients with suspected coronary
artery disease (CAD) in comparison to invasive angiography.
Methods: Fifty-four patients (60 ± 10 years, 35 men, CAD 48%) underwent CMR including MRCA
(steady state free precession, navigator whole heart approach, spatial resolution 0.7 × 0.7 × .0.9
mm, trigger delay and temporal resolution adjusted individually), stress PERF (adenosine 140 μg/
min/kg), rest PERF (SSFP, 3 short axis, 1 saturation prepulse per slice) and LGE (3D inversion
recovery technique) using Gd-BOPTA. Images were analyzed visually. Stenosis >50% in invasive
angiography was considered significant.
Results:  Mean study time was 68 ± 11 minutes. Sensitivity for PERF, LGE, MRCA and the
combination of PERF/LGE and PERF/LGE/MRCA was 87%, 50%, 91%, 88% and 92%, respectively
and specificity 88%, 96%, 46%, 88% and 56%, respectively. If image quality of MRCA was excellent
(n = 18) the combination of MRCA/PERF/LGE yield a sensitivity of 86% and specificity of 91%.
However, no test or combination improved diagnostic performance significantly compared to PERF
alone.
Conclusion: In patients with CAD, the combination of stress PERF, LGE and MRCA is feasible.
When compared to invasive angiography, adenosine stress perfusion outperforms CMR coronary
angiography in direct comparison and yields the best results with non-significant improvement in
combination with LGE and significant deterioration in combination with MRCA. MRCA may be of
additional value only in a minority of patients with excellent image quality.
Published: 17 October 2008
Journal of Cardiovascular Magnetic Resonance 2008, 10:45 doi:10.1186/1532-429X-10-45
Received: 12 May 2008
Accepted: 17 October 2008
This article is available from: http://www.jcmr-online.com/content/10/1/45
© 2008 Klein et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Journal of Cardiovascular Magnetic Resonance 2008, 10:45 http://www.jcmr-online.com/content/10/1/45
Page 2 of 10
(page number not for citation purposes)
Background
Cardiovascular magnetic resonance (CMR) has emerged
as a useful clinical tool for the detection and characteriza-
tion of coronary artery disease (CAD). It offers functional
studies for the detection of ischemia, tissue characterisa-
tion for the detection and quantification of myocardial
infarction as well as luminal assessment of the coronary
arteries. Several single and one multicenter trial have dem-
onstrated high diagnostic accuracy of adenosine perfusion
imaging [1-7] with potential advantages (e.g. higher spa-
tial resolution) compared to nuclear imaging [8]. Infarct
imaging has proven to be in concordance with histology
[9] and more sensitive compared to nuclear imaging
[10,11], as small subendocardial defects can be detected.
In patients without previous history of CAD the combina-
tion of perfusion and infarct imaging can increase diag-
nostic accuracy compared to perfusion alone, especially
by increasing specificity [2,12] in cases with suboptimal
perfusion image quality (IQ). A recent meta-analysis of
published data on CMR coronary angiography (MRCA)
demonstrated a sensitivity and specificity of 88% and
56%, respectively[13]. The only multicenter trial con-
firmed a high sensitivity and low specificity for the detec-
tion of CAD [14]. More recent single center CMR-coronary
angiographic data demonstrated superior results, espe-
cially improved specificity [15,16]. Aim of the present
study was to assess the feasibility and diagnostic accuracy
of CMR stress/rest adenosine perfusion, infarct imaging
and coronary angiography and their combination for the
detection of significant stenosis in patients with suspected
CAD scheduled for invasive coronary angiography.
Methods
The prospective study was approved by the institutional
review board of the Charité, Berlin, Germany. Fifty-five
consecutive patients with suspected CAD who were
referred for invasive coronary angiography were prospec-
tively included into the study after given informed con-
sent. Patients with contraindications for CMR, known
myocardial infarction, atrial fibrillation, instable angina,
AV block > I°, obstructive lung disease or claustrophobia
were excluded from the study.
Magnetic resonance imaging
All patients were examined in supine position using a 1.5
Tesla scanner (Intera, Philips Medical Systems, Nether-
lands). A five-element cardiac synergy coil was used for
signal detection. The study protocol is shown in Figure 1.
The 4-chamber view was imaged with 40 phases/cardiac
cycle to visually determine the timing and duration of the
individual cardiac rest period [17]. To adequately visual-
ize the most cranial and caudal dimension of the coronary
system, a coronary whole heart scout in transversal orien-
tation was used. A sufficient number of strictly transversal
slices (120–140) were then obtained to cover the whole
heart (steady state free precession (SSFP)), fat suppres-
sion, T2 preparation pre-pulse; SENSE factor 1.7; TR/TE/
FA 4.6/2.3/100°; trigger delay and temporal resolution
adjusted to individual diastolic coronary rest period). Spa-
tial resolution was nearly isotropic (0.7 × 0.7 × 0.9 mm3).
Breathing motion was compensated using a cranio-caudal
navigator technique. The gating window was set to 6 mm.
First pass stress perfusion (PERF) (SSFP, TE/TR/FA 2.7/
1.4/50°, 1 saturation prepulse per slice, 3 short axis slices/
heart beat) was begun after 3 minutes of i.v. adenosine
infusion (140 μg/min/kg body weight) and a peripheral
bolus of 0.05 mmol/kg body weight Gd-BOPTA (Multi-
Hance©, Altana, Germany). After a period of app. 10 min-
utes to allow for clearance of the contrast agent, rest
perfusion (0.05 mmol/kg Gd-BOPTA) was performed,
Study protocol and duration of the different examinations Figure 1
Study protocol and duration of the different examinations. Cine + scout includes the coroscout, left ventricular func-
tion and the determination of beginning and duration of the cardiac resting period.
survey Cine +scout MRCA stress PERF break (app 10 min) rest  PERF break (app 10 min) enhancement
Adenosine (140μg/kg/min)
0.05mmol/kg
Gd-BOPTA
0.05mmol/kg
Gd-BOPTA
0.1mmol/kg
Gd-BOPTA
4-5min
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followed by additional 0.1 mmol/kg Gd-BOPTA. Late
gadolinium enhancement (LGE) was imaged in short axis
and the standard long axis views after 10 minutes using an
inversion recovery 3D-turbo-gradient-echo-technique
(TE/TR/FA 2.3/4.8/15°, spatial resolution 1.4 × 1.4 × 5.0
mm3, acquisition time 215 ms, prepulse delay 225 – 300
ms).
Image Analysis
All CMR images were evaluated visually on the commer-
cially available ViewForum (Philips, Best, Netherlands)
using the 16 segment model by agreement of two experi-
enced (>5 years of CMR) observers fully blinded to the
results of the invasive coronary angiography and the other
CMR exams. For the combination of tests a patient was
classified as having CAD if any of the tests was positive.
Perfusion and late Gadolinium enhancement
For the perfusion analysis the adenosine perfusion images
were compared side by side with the rest perfusion (e.g.
artifacts). In a second seperate turn the perfusion images
were analysed in combination with the enhancement
images. The presence and transmural extent of a perfusion
defect were determined in the dynamic image with the
maximal extent of the defect. A perfusion defect was
graded visually as subendocardial (<75%) or transmural
(≥ 75%). Any regional stress induced defect or late Gado-
linium enhancement in any segment was considered pos-
itive.
CMR coronary angiography
For the visual assessment of coronary artery stenoses, the
unprocessed raw data were used. The diagnostic perform-
ance was determined in a 16-segment model: (i) left main
segment, (ii) proximal, (iii) mid and (iv) distal segment of
LAD, (v) first and (vi) second diagonal branch, (vii) prox-
imal, (viii) mid and (ix) distal segment of LCX, (x) first
and (xi) second marginal branch, (xii) proximal, (xiii)
mid and (xiv) distal segment of RCA, (xv) right posterola-
teralis segment, and (xvi) posterolateral descending artery
segment.
Image quality of the entire 3D-data set was visually graded
as excellent (coronary artery visible with sharply defined
borders), good (mildly blurred borders), moderate (mod-
erately blurred borders) or non-diagnostic (markedly
blurred borders) [14]. The latter were not included into
the analysis. Patients were classified as having or not hav-
ing CAD. For the final results only vessels with a diameter
suitable for revascularization (≥ 2 mm, visual assessment)
in invasive angiography were included.
Invasive coronary angiography
All coronary X-ray angiographies were performed within
24 hours after CMR examination. Two experienced inter-
ventional cardiologist blinded to the results of the CMR
examinations visually evaluated the angiograms. A hemo-
dynamically significant coronary stenosis was defined as
>50% luminal diameter narrowing.
Statistics
Statistical analysis was performed using SPSS 12.0.1 for
Windows (SPSS Inc.). For all continuous parameters
mean ± SD are given. Sensitivity, specificity, and diagnos-
tic accuracy including the confidence intervals were calcu-
lated according to standard definitions. For comparison
between the tests a nonparametric test (McNemar) was
used. Values <0.05 were considered significant. For the
combined interpretation, patients with a non-diagnostic
perfusion scan, but pathological LGE or MRCA were
included, those with a non-diagnostic perfusion scan and
a negative LGE or MRCA excluded from the analysis.
Results
The patients characteristics are shown in Table 1. Of the
54 patients 26 (48%) had significant CAD (12 one-vessel,
8 two-vessel and 6 three-vessel disease). Mean study time
(patient in the scanner) was 68 ± 11 minutes (range 52–
118 min) mainly due to different durations of data acqui-
sition of MRCA. Study times of the different modules are
shown in Figure 1. Table 2 demonstrates the sensitivities,
specificities and diagnostic accuracy.
Perfusion/late gadolinium enhancement
PERF was not performed in 3 (6%) patients, due to possi-
ble aortic stenosis unknown prior to the CMR-exam (1) or
severe dyspnoea during adenosine (2). Analysis could not
be performed in 2 (4%) patients due to non diagnostic
image quality (IQ) due to breathing (1) and trigger arte-
facts (1). Heart rate increased (p < 0.001) from 72 ± 13/
min (52–109/min) to 88 ± 14/min (54–127/min) with
adenosine, blood pressure from 131 ± 19/73 ± 12 mmHg
to 133 ± 21/73 ± 13 mmHg (p > 0.05). Over all and vessel
specific diagnostic performance is shown in Table 2. Of
the 10 patients with a transmural perfusion defect, 6 had
subendocardial and 3 transmural LGE.
Two of 3 false positive readings were in the RCA territory.
One patient had a regional wall motion abnormality, sub-
endocardial enhancement and a perfusion defect at the
same site, however, without high grade coronary stenosis,
probably due to a small infarction without remaining ste-
nosis.
Of the 3 patients with false negative readings 2 had one-
vessel-disease (distal LAD and first diagonal branch), the
other three-vessel-disease with 50% left main and 90%
medial RCA. Sensitivity of the 14 patients with proximal
CAD was 93% (13/14). Enhancement could be analysedJournal of Cardiovascular Magnetic Resonance 2008, 10:45 http://www.jcmr-online.com/content/10/1/45
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Table 1: Patient characteristics
Entire group (n = 54) CAD (n = 26) No CAD (n = 28) p
Male/female 35/19 22/4 13/15 0.004
Age (years) 60 ± 10 (37–78) 60 ± 9 (41–77) 60 ± 11 (37–78) 0.73
Weight (kg) 81 ± 15 (54–118) 86 ± 15 (54–118) 76 ± 14 (55–104) 0.03
BMI 27.6 ± 4.1 (21.1–36.7) 28.4 ± 4.2 (21.1–36.7) 26.8 ± 3.9 (21.5–34.9) 0.10
Typical angina 30 (56%) 20 (77%) 10 (36%) 0.003
Atypical angina 15 (28%) 4 (15%) 11 (39%) 0.05
Dyspnoea on exertion 21 (39%) 6 (23%) 15 (54%) 0.02
DM 12 (22%) 5 (19%) 7 (25%) 0.61
Hypertension 37 (69%) 22 (85%) 15 (54%) 0.02
Smoker 18 (33%) 11 (42%) 7 (25%) 0.18
Hypercholesterinemia 41 (76%) 21 (81%) 20 (71%) 0.43
Family history 17 (31%) 9 (35%) 8 (29%) 0.64
Pathological ECG 16 (30%) 9 (35%) 7 (25%) 0.68
LV ejection fraction 59 ± 9% (31–71) 57 ± 10% (31–67) 61 ± 7% (39–71) 0.18
Positive nuclear study 13 (24%) 6 (23%) 7 (25%)
Positive stress echo 5 (9%) 1 (4%) 4 (14%)
Positive exercise test 8 (15%) 6 (23%) 2 (7%)
CAD = coronary artery disease; BMI = body mass index; DM = Diabetes mellitus; ECG = electrocardiography; LV = left ventricular.
Table 2: Diagnostic accuracy of the individual test and their combination on a patient basis
Sensitivity (%) (95% CI) Specificity (%) (95% CI) Accuracy (%) (95% CI)
PERF (n = 49) 87 (65;97) [20/23] 88 (69;97) [23/26)] 88 (75;95) [43/49]
LGE (n = 54) 50 (30;70) [13/26] 96 (80;100) [27/28] 74 (60;85) [40/54]
MRCA (n = 46) 91 (69;98) [20/22] 54 (33;74) [13/24] 70 (54;82) [32/46]
PERF/LGE (n = 51) 88 (68;97) [22/25] 88 (69;97) [23/26] 88 (75;95) [45/51]
PERF/LGE/MRCA (n = 51) 92 (73;99) [24/26] 60 (39;78) [15/25] 75 (60;80) [38/51]
PERF = adenosine stress perfusion, LGE = late gadolinium enhancement, MRCA = magnetic resonance coronary angiography.Journal of Cardiovascular Magnetic Resonance 2008, 10:45 http://www.jcmr-online.com/content/10/1/45
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in all patients. Fifteen patients showed some degree of
enhancement.
MRCA
Scan duration depended on heart rate (73 ± 15 bpm,
range 54–115 bpm) and navigator efficiency (52 ± 13%,
range 16–79%) and lasted 6'15" ± 1'36" (range 3'57" –
12'4"). In 7 patients MRCA had to be restarted due to dia-
phragmatic drift. Images could be acquired in all patients,
however, 8 patients (15%) yielded non-diagnostic IQ. Of
the remaining, 18 (33%) had excellent, 17 (31%) good
and 11 (20%) moderate IQ. Of the 714 segments 521 had
a diameter ≥ 2 mm visually defined by invasive angiogra-
phy, of which 404 (78%) were visualized by CMR (100%
of proximal, 87% of medial and 65% of distal segments,
42% of diagonal, 40% of marginal and 54% of RCA side
branches). Diagnostic accuracy is shown in Tables 2 and
3. MRCA was significantly inferior (p = 0.002) to PERF.
Sensitivity and specificity on a segmental basis was 74%
(32 of 43) and 89% (323 of 361), respectively. If IQ is
taken into account sensitivity, specificity and diagnostic
accuracy on a patient basis were 86%, 91% and 88% for
excellent image quality, 100%, 22% and 61% for good
image quality and 86%, 25% and 64% for moderate
image quality, respectively (Table 4). Body weight and
BMI of patients with excellent IQ was 71 ± 11 kg and 25.6
± 3.4 kg/m2, compared to 85 ± 15 kg and 28.4 ± 4.0 kg/m2
in the remaining patients.
Combination
The sensitivities and specificities shown in Tables 2 and 3
were defined if any of the tests – perfusion, enhancement
or MRCA – was positive. If LGE was added to the CMR
exam, sensitivity increased (p > 0.05) because two
patients without PERF (not performed or non-diagnostic)
showed enhancement. Adding LGE did not change the
results, if only patients, in whom PERF and LGE were
diagnostic were analyzed. If MRCA is added, sensitivity
further increased, however specificity decreased (p =
0.001) due to the rate of false positive readings. Subgroup
analysis for patients with excellent or both, excellent and
good MRCA IQ are shown in Table 4. The combined tests
in patients with excellent IQ did not, in patients with
excellent and good IQ did differ statistically significant (p
= 0.02). In the five patients without PERF 2 had non diag-
nostic IQ in MRCA, 2 were correct positive and one was
false positive.
Discussion
The present study demonstrates the feasibility of the com-
bination of perfusion, infarct and coronary artery imaging
in patients with suspected CAD. Perfusion imaging by
itself is the most accurate test. The accuracy can not be sig-
nificantly improved by adding late gadolinium enhance-
ment. CMR coronary angiography is significantly inferior
to PERF and its addition to PERF/LGE decreases diagnos-
tic accuracy. Even if MRCA image quality is excellent it
does not show an additional benefit in predicting luminal
stenoses.
As invasive coronary angiography includes disadvantages
as invasiveness, exposure to radiation, potential life
threatening risk, limited information about coronary
hemodynamics and high cost, a non invasive modality
with the potential to detect and localize ischemia and/or
infarction with additional information on coronary anat-
Table 3: Sensitivity and specificity in percent (%) including the 95% confidence interval of the individual test and their combination on a 
coronary artery basis
LAD LCX RCA
Sens Spec Sens Spec Sens Spec
PERF 
(n = 49)
86 (56;97) 
[12/14]
97 (83;100) 
[34/35]
73 (39;93) 
[8/11]
89 (74;97) 
[34/38]
75 (43;93) 
[9/12]
92 (77;98) 
[34/37]
LGE 
(n = 54)
31 (12;59) 
[5/16]
100 (89;100) 
[38/38]
38 (15;68) 
[5/13]
100 (89;100) 
[41/41]
50 (22;78) 
[6/12]
95 (83;99) 
[40/42]
MRCA 
(n = 46)
100 (72;100) 
[13/13]
64 (45;79) 
[21/33]
75 (43;93) 
[9/12]
85 (68;94) 
[29/34]
82 (48;97) 
[9/11]
83 (66;93) 
[29/35]
PERF/LGE 
(n = 51)
87 (58;98) 
[13/15]
94 (80;99) 
[34/36]
69 (39;90) 
[9/13]
89 (74;97) 
[34/38]
75 (43;93) 
[9/12]
85 (69;94) 
[33/39]
PERF/LGE/MRCA 
(n = 51)
100 (76;100) 
[16/16]
60 (42;76) 
[21/35]
85 (54;97) 
[11/13]
75 (57;87) 
[27/36]
100 (70;100) 
[12/12]
72 (55;85) 
[26/36]
LAD = left anterior descending, LCX = left circumflex, RCA = right coronary artery, Sens = sensitivity, Spec = specificity, PERF = adenosine stress 
perfusion, LGE = late gadolinium enhancement, MRCA = magnetic resonance coronary angiography.Journal of Cardiovascular Magnetic Resonance 2008, 10:45 http://www.jcmr-online.com/content/10/1/45
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omy, location and severity of coronary lesions could bet-
ter select patients to undergo an invasive procedure. CMR
can offer a combined protocol in little more than 1 hour
with high patient acceptance (all patients in the current
study). Potentially, total scan time could be reduced to
less than one hour by performing the MRCA between the
two perfusion scans [18].
Perfusion/late gadolinium enhancement
First pass perfusion is the most widely used CMR-tech-
nique for the detection of reduced myocardial blood flow
and yields superior results compared to SPECT [8]. Our
results (sensitivity/specificity 87%/88%) are similar to
published data with sensitivities of 84%–93% and specif-
icities of 58%–85% [1-3,6,19]. Proximal CAD was
detected in all but one patient. This patient with signifi-
cant left main (50%) and RCA stenosis, however, did not
demonstrate an adenosine induced change in heart rate,
blood pressure or of the myocardial perfusion reserve
index (upslope) in any of the segments, even if the epicar-
dium was measured separately (data not shown).
Although the patient denied any nicotine, caffeine or
nitrate consumption 24 h prior to the examination, the
lack of any adenosine effect may be the main reason for
the false negative result. In general, first pass perfusion in
patients with three vessel disease has a high sensitivity.
This is supported by the fact that all but one patient with
a transmural stress perfusion defect also had enhance-
ment at this site, while patients even with high grade ste-
nosis, but without enhancement had subendocardial
stress induced defects only. This demonstrates the ability
of the myocardium to preserve perfusion in the epicar-
dium during adenosine vasodilatation even in high grade
stenosis. It therefore seems unlikely that 3-vessel-disease
has a globally (endo- and epicardial) reduced perfusion
reserve that remains undetected by CMR, although the
ability of the exact vessel specific localization of ischemia
in multi-vessel disease may be reduced [12]. The other
two false negative results were in patients with distal and
side branch CAD.
LGE is an excellent technique for the detection and quan-
tification of myocardial infarction [9,20]. Whereas a posi-
tive finding in a patient without previously known CAD
has a strong indication for coronary angiography, its value
to characterize patients for myocardial ischemia is lim-
ited.
MRCA
Although using SSFP with a better signal and contrast to
noise ratio in comparison to previous T2 prepared turbo
gradient techniques [21,22] our approach resulted in a
low specificity. In addition15% of patients had non-diag-
nostic image quality, 35% of distal segments and 60% of
side branches were non-diagnostic. Therefore, the current
implementation of MRCA is still not sufficiently reliable
for the diagnosis and characterisation of CAD. Only in
patients with excellent IQ (33%) an acceptable diagnostic
accuracy was achieved. Even in patients with good IQ
(31%) specificity already dropped considerably, appar-
ently as MRCA defects can either represent true lesions or
artefacts. However, due to the small number these results
have to be interpreted with care and need to be confirmed
in a larger patient group. Our results remain inferior to
recently published data [15,16]. This may be due to sev-
eral reasons. Jahnke et al used a sophisticated motion
adaptation technique (affine transformation) not availa-
ble at the time of the study and also not available for most
sites performing CMR studies. In this study analysis was
performed on a segmental basis, which yields a higher
specificity due to the high number of normal segments. In
addition, the whole image procedure was optimized on
coronary artery imaging only, allowing up to 30 minutes
just for MRCA imaging (without using parallel imaging).
However, segmental comparison between CMR and inva-
sive angiography bears the problem of anatomical corre-
Table 4: Diagnostic accuracy in patients with excellent and excellent/good image quality in MRCA
Sensitivity (%) (95% CI) Specificity (%) (95% CI)
PERF/LGE (IQ in MRCA excellent) 71 (30;95) [5/7] 100 (68;100) [11/11]
MRCA (§) (IQ in MRCA excellent) 86 (42;99) [6/7] 91 (57;100) [10/11]
PERF/LGE/MRCA (§) (IQ in MRCA excellent) 86 (42;99) [6/7] 91 (57;100) [10/11]
PERF/LGE (IQ in MRCA excellent or good) 87 (58;98) [13/15] 90 (68;98) [19/21]
MRCA (*) (IQ in MRCA excellent or good) 93 (66 ;100) [14/15] 57 (34 ;77) [12/21]
PERF/LGE/MRCA (*) (IQ in MRCA excellent or good) 93 (66;100) [14/15] 57 (34;77) [12/21]
IQ = image quality, PERF = adenosine stress perfusion, LGE = late gadolinium enhancement, MRCA = magnetic resonance coronary angiography. (*) 
= p < 0.05 compared to PERF/LGE, (§) = p > 0.05 compared to PERF/LGEJournal of Cardiovascular Magnetic Resonance 2008, 10:45 http://www.jcmr-online.com/content/10/1/45
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lation as segmental definition depends on the
identification of side branches that may be different
within the two methods, especially as side branches in
CMR may easily be missed (more than 50% in our study).
Sakuma et al. achieved superior image quality and specif-
icity in 131 Japanese patients with suspected CAD using a
similar MRCA protocol. Two major differences to our
approach may explain this superior accuracy. First, their
patient population was much slimmer (63.4 ± 10.3 kg)
compared to ours (81 ± 15 kg). Interestingly, our sub-
group of patients with excellent IQ was significantly thin-
ner (71 ± 11 kg), than the overall group. A number of
factors (e.g. breathing patterns, heart rate, heart rate varia-
bility, scan time, etc.) may influence image quality of free-
breathing MRCA. Sakuma et al supplied nitrates before
MRCA, which, however, would have influenced our per-
fusion results. We believe that the current strength or CMR
lies in the assessment of hemodynamic consequences of
coronary lesions with a growing contribution of vascular
morphology. We would, thus, rather integrate MRCA into
ischemia testing than improve MRCA on the cost of not
performing stress testing. This is of special importance, as
it was recently demonstrated that CMR stress testing
[23,24] and the detection of scar [25] has a prognostic
value in patients with suspected CAD. Potential improve-
ment in MRCA may be achieved with the use of higher
field strength (e.g. 3T) [26] or the use of intravascular con-
trast agents [27,28].
Combination of tests
Figures 2 and 3 show examples of a patient without and
with significant CAD. The best result was achieved with
the combination of stress perfusion and late gadolinium
enhancement (not significant). However, the combina-
tion was only superior to perfusion alone, as perfusion
was non-diagnostic in two patients with a positive late
gadolinium enhancement. Improved sensitivity can be
achieved in patients with chronic infarction without a
stress induced perfusion defect. Myocardial scar, however,
has a low perfusion at rest with hardly any perfusion
reserve [29] and therefore, the defect should be more pro-
nounced during stress. Small subendocardial infarcts may
be detected by LGE due to the high spatial resolution in
comparison to perfusion, which, however, was not the
case in our patient population. Although not strongly sup-
ported by our study, we support the use of LGE when a
perfusion study is performed, as the presence of scar is an
important information, not necessary drawn from per-
fusion alone and if present adding confidence to diagnose
CAD. The addition of MRCA did not improve accuracy.
The main issue remains the difficulty to achieve adequate
image quality within the combined approach. With the
current techniques, the role of MRCA remains limited,
except to gain further confidence if excellent image quality
can be obtained. This may be of specific importance in
patients with microvascular disease who may have a pos-
itive perfusion scan, but no treatable epicardial stenosis.
Our results, however, are different to a recent report by
Plein et al. [30] who demonstrated a small, but additional
value of MRCA compared to perfusion alone. Possible
explanations could be first the very different patient pop-
ulation with non-ST-segment elevation acute coronary
syndrome and a high prevalence of significant CAD. Sec-
ond, Plein et al used a targeted compared to a whole heart
approach and third, the authors analysed the proximal
and medial portions of the left and circumflex coronary
only and were allowed to discard images with poor IQ or
significant artefacts, thus, possibly reducing false positive
readings.
Patient population
There was an intermediate pre-test probability for CAD
(48%) with similar cardiovascular risk factors in the
groups with and without CAD (except hypertension). In
both groups there were individuals with typical and atyp-
ical angina, dyspnoea on exertion and ECG changes,
therefore making a non-invasive test desirable. Care was
taken to include patients prospectively without exclusion
of unfavourable patients like high BMIs or diabetes (Table
1).
Limitations
There are, however, certain limitations to the study. Due
to the rapid development, especially of MRCA, there are
techniques available that may outperform the method
used in our study. The technique applied, however, is
commercially available to many cardiovascular CMR
users without research tools. Therefore, this technique
needs to be evaluated for its clinical use in comparison
with functional tests. The patient number is relatively low.
We are, however, confident that even in a larger patient
population, the results of the limited advantage of MRCA
would not have changed as only 33% of patients achieved
image quality that may be of additional value. Our
patients were referred for invasive coronary angiography,
therefore representing a highly selected patient popula-
tion. Our results can therefore not be transferred to a more
unselected group of patients. And last, we have compared
a functional imaging test (PERF) with the morphology of
the coronary arteries as the gold standard without the
addition of additional functional assessment. Therefore
we cannot be absolutely certain about the "real" func-
tional relevance of a stenosis. However, although not
optimal, the majority of studies assessing non-invasive
testing have compared their results to angiography.
Conclusion
In conclusion, the combination of functional and mor-
phological studies with CMR in one session is feasible.
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Example of one patient without significant CAD Figure 2
Example of one patient without significant CAD. Normal findings in stress- and rest-PERF (short axis views), late gado-
linium enhancement (short axis view) and magnetic resonance coronary angiography (SoapBubble software, Philips Medical Sys-
tems, Best, the Netherlands). Invasive angiography demonstrates normal coronary arteries.
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with suspected CAD and outperforms CMR coronary ang-
iography. It should be combined with late Gadolinium
enhancement, however, an additional benefit of CMR cor-
onary imaging may only be demonstrated in patients with
excellent image quality.
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